BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33640268)

  • 1. Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
    Chan CK; Sieber FE; Blennow K; Inouye SK; Kahn G; Leoutsakos JS; Marcantonio ER; Neufeld KJ; Rosenberg PB; Wang NY; Zetterberg H; Lyketsos CG; Oh ES
    Am J Geriatr Psychiatry; 2021 Dec; 29(12):1212-1221. PubMed ID: 33640268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of insulin resistance with delirium and CSF biomarkers of Alzheimer's disease in elderly patients with hip fracture.
    Wang J; Shuang P; Li Z; Zhao L; Wang X; Liu P
    Aging Clin Exp Res; 2023 Jul; 35(7):1521-1529. PubMed ID: 37166562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.
    Idland AV; Wyller TB; Støen R; Eri LM; Frihagen F; Ræder J; Chaudhry FA; Hansson O; Zetterberg H; Blennow K; Bogdanovic N; Brækhus A; Watne LO
    J Alzheimers Dis; 2017; 55(1):371-379. PubMed ID: 27662296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative cerebrospinal fluid biomarkers may be associated with postoperative delirium in patients undergoing knee/hip arthroplasty: the PNDABLE study.
    Lin Y; Yu N; Lin X; Deng X; Liu F; Tao H; Dong R; Wang B; Bi Y
    BMC Geriatr; 2023 May; 23(1):282. PubMed ID: 37165310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
    Halaas NB; Zetterberg H; Idland AV; Knapskog AB; Watne LO; Blennow K
    J Alzheimers Dis; 2021; 81(2):667-677. PubMed ID: 33814433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid β-amyloid and tau are not associated with risk of delirium: a prospective cohort study in older adults with hip fracture.
    Witlox J; Kalisvaart KJ; de Jonghe JF; Verwey NA; van Stijn MF; Houdijk AP; Traast HS; MacLullich AM; van Gool WA; Eikelenboom P
    J Am Geriatr Soc; 2011 Jul; 59(7):1260-7. PubMed ID: 21718268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
    Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
    Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease.
    García-Escobar G; Puig-Pijoan A; Puente-Periz V; Fernández-Lebrero A; María Manero R; Navalpotro-Gómez I; Suárez-Calvet M; Grau-Rivera O; Contador-Muñana J; Cascales-Lahoz D; Duran-Jordà X; Boltes N; Pont-Sunyer MC; Ortiz-Gil J; Carrillo-Molina S; López-Villegas MD; Abellán-Vidal MT; Martínez-Casamitjana MI; Hernández-Sánchez JJ; Padrós-Fluvià A; Peña-Casanova J; Sánchez-Benavides G
    J Alzheimers Dis; 2023; 92(4):1303-1321. PubMed ID: 37038810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
    Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia.
    Oh ES; Blennow K; Bigelow GE; Inouye SK; Marcantonio ER; Neufeld KJ; Rosenberg PB; Troncoso JC; Wang NY; Zetterberg H; Sieber FE; Lyketsos CG
    PLoS One; 2018; 13(9):e0204695. PubMed ID: 30252906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta 1-42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer's disease.
    Shea YF; Chu LW; Mok MY; Lam MF
    J Nephrol; 2014 Apr; 27(2):217-20. PubMed ID: 24473733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
    Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
    J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
    Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
    Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.